Immune therapy in inflammatory bowel disease and models of colitis.

Immune therapy in inflammatory bowel disease and models of colitis.

BACKGROUND: A proliferation of animal models has not only improved our understanding of inflammatory bowel disease, it has also formed the basis of new treatment strategies. METHODS: A search was conducted using the National Library of Medicine for articles discussing immune therapies for inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, B, Powrie, F, Mortensen, N
Formato:	Journal article
Lenguaje:	English
Publicado:	2001

Ejemplares similares

Anti-interleukin 12 antibody prevents colitis in a murine T cell transfer model of inflammatory bowel disease
por: Singh, B, et al.
Publicado: (2003)

Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
por: Powrie, F, et al.
Publicado: (1995)

Cytokine requirements in models of inflammatory bowel disease
por: Pearson, C, et al.
Publicado: (2011)

Regulatory T cells and inflammatory bowel disease.
por: Groux, H, et al.
Publicado: (1999)

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
por: Geremia, A, et al.
Publicado: (2011)

T cells in inflammatory bowel disease: protective and pathogenic roles.
por: Powrie, F
Publicado: (1995)

Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
por: Powrie, F, et al.
Publicado: (2004)

Intestinal homeostasis and its breakdown in inflammatory bowel disease.
por: Maloy, K, et al.
Publicado: (2011)

Translating immunology into therapeutic concepts for inflammatory bowel disease
por: Uhlig, HH, et al.
Publicado: (2018)

Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
por: Uhlig, H, et al.
Publicado: (2009)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Ahmed F. Khalil, et al.
Publicado: (2020-11-01)

Cytokine networks in the pathophysiology of inflammatory bowel disease
por: Friedrich, M, et al.
Publicado: (2019)

An immune therapy model for effective treatment on inflammatory bowel disease.
por: Anna Park, et al.
Publicado: (2020-01-01)

Control of experimental inflammatory bowel disease by regulatory T cells.
por: Asseman, C, et al.
Publicado: (2000)

Control of experimental inflammatory bowel disease by regulatory T cells
por: Asseman, C, et al.
Publicado: (2000)

Human ILC-T-cell interactions in inflammatory bowel disease
por: Schaupp, A, et al.
Publicado: (2014)

Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells.
por: Read, S, et al.
Publicado: (2001)

Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.
por: Cahill, R, et al.
Publicado: (1997)

Strongyloides Colitis as a Harmful Mimicker of Inflammatory Bowel Disease
por: Julio Poveda, et al.
Publicado: (2017-01-01)

Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
por: Shun-Wen Hsiao, et al.
Publicado: (2022-11-01)

Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases
por: Istvan Fedor, et al.
Publicado: (2023-02-01)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Akshita Gupta, et al.
Publicado: (2017-07-01)

The differentiation of amebic colitis from inflammatory bowel disease on endoscopic mucosal biopsies
por: Reecha Singh, et al.
Publicado: (2015-01-01)

The role of IL-10 in inflammatory bowel disease: "of mice and men".
por: Leach, M, et al.
Publicado: (1999)

Living with Inflammatory Bowel Disease: A Crohn’s and Colitis Canada Survey
por: Helen M Becker, et al.
Publicado: (2015-01-01)

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
por: Ajit Sood, et al.
Publicado: (2021-04-01)

The prevalence of inflammatory bowel diseases, microscopic colitis, and colorectal cancer in patients with irritable bowel syndrome
por: Magdy El-Salhy, et al.
Publicado: (2011-07-01)

HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease.
por: Roskell, D, et al.
Publicado: (1995)

Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer
por: Chen T, et al.
Publicado: (2025-01-01)

Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease
por: Michelle Temby, et al.
Publicado: (2023-11-01)

Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis
por: Ram Hari Dahal, et al.
Publicado: (2023-05-01)

Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir
por: Iftikhar Ahmed, et al.
Publicado: (2018-10-01)

Concept «grade-stage» in morphological diagnostics of chronic colitis in inflammatory bowel disease
por: A. S. Tertychnyy, et al.
Publicado: (2023-11-01)

Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer
por: Chan Hyung Lee, et al.
Publicado: (2023-07-01)

Long-Term Follow Up of Patients Treated for Inflammatory Bowel Disease and Cytomegalovirus Colitis
por: Gurtej Singh, et al.
Publicado: (2024-09-01)

Non-specific colitis among patients with colitis: frequency and relation to inflammatory bowel disease, a prospective study
por: Mohamed H. Emara, et al.
Publicado: (2019-10-01)

Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC)
por: Edda Russo, et al.
Publicado: (2023-05-01)

Prostaglandins in Inflammatory Bowel Disease Therapy
por: Lonnie R Empey, et al.
Publicado: (1993-01-01)

Trends in Inflammatory Bowel Disease Therapy
por: L Sutherland, et al.
Publicado: (1990-01-01)

A role of bacteria in inflammatory bowel disease evoked in animal models
por: Strus, M, et al.
Publicado: (2005)